Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 1,990 · see citing works

International trial of the Edmonton protocol for islet transplantation

Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942 · see citing works

Lethal effect of the anti-Fas antibody in mice

Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881 · see citing works

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827 · see citing works

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation

Ju, S., Panka, D., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D., Stanger, B., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,709 · see citing works

mTOR regulates memory CD8 T-cell differentiation

Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · see citing works

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas

Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314 · see citing works

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

Battaglia, M., Stabilini, A., & Roncarolo, M. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,203 · see citing works

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

Lahl, K., Loddenkemper, C., Drouin, C. E., Freyer, J., Arnason, J. E., Eberl, G., Hamann, A., Wagner, H., Huehn, J., & Sparwasser, T. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061852 · Cited by 918 · see citing works

The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin

Rao, R. R., Li, Q., Odunsi, K., & Shrikant, P. A. (2010) · Immunity · doi:10.1016/j.immuni.2009.10.010 · Cited by 656 · see citing works

Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery

Phelps, E. A., Enemchukwu, N. O., Fiore, V. F., Sy, J. C., Murthy, N., Sulchek, T., Barker, T. H., & Garcı́a, A. J. (2011) · Advanced Materials · doi:10.1002/adma.201103574 · Cited by 541 · see citing works

Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice

Lau, H., Yu, M., Fontana, A., & Stoeckert, C. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 492 · see citing works

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Bækkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 448 · see citing works

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.

Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X.-H., & Ferguson, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 406 · see citing works

Differential impact of mammalian target of rapamycin inhibition on CD4 +CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

Zeiser, R., Leveson-Gower, D. B., Zambricki, E. A., Kambham, N., Beilhack, A., Loh, J., Hou, J.-Z., & Negrin, R. S. (2008) · Blood · doi:10.1182/blood-2007-06-094482 · Cited by 402 · see citing works

Membrane-bound Fas ligand only is essential for Fas-induced apoptosis

O’ Reilly, L. A., Tai, L., Lee, L., Kruse, E. A., Grabow, S., Fairlie, W. D., Haynes, N. M., Tarlinton, D. M., Zhang, J.-G., Belz, G. T., et al. (2009) · Nature · doi:10.1038/nature08402 · Cited by 400 · see citing works

Acceleration of Diabetes in Young Nod Mice with a CD4 + Islet-specific T Cell Clone

HASKINS, K. M., & MCDUFFIE, M. J. (1990) · Science · doi:10.1126/science.2205920 · Cited by 386 · see citing works

Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in β Cells

Yoon, J.-W., Yoon, C.-S., Lim, H.-W., Huang, Q. Q., KANG, Y. Y., Pyun, K. H., Hirasawa, K., Sherwin, R. S., & Jun, H. (1999) · Science · doi:10.1126/science.284.5417.1183 · Cited by 247 · see citing works

Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival

Min, W., Gorczynski, R. M., Huang, X., Kushida, M. M., Kim, P., Obataki, M., Lei, J., Suri, R. M., & Cattral, M. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.161 · Cited by 234 · see citing works

Microfluidic‐Based Generation of Size‐Controlled, Biofunctionalized Synthetic Polymer Microgels for Cell Encapsulation

Headen, D. M., Aubry, G., Lu, H., & Garcı́a, A. J. (2014) · Advanced Materials · doi:10.1002/adma.201304880 · Cited by 198 · see citing works

T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins

Roep, B. O., Arden, S. D., de vries, R. R. P., & Hutton, J. C. (1990) · Nature · doi:10.1038/345632a0 · Cited by 185 · see citing works

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

Roep, B. O., Stobbe, I., Duinkerken, G., ROOD, J. J. V., Lernmark, Å., Keymeulen, B., PIPELEERS, D. G., Claas, F. H. J., & de Vries, R. R. (1999) · Diabetes · doi:10.2337/diabetes.48.3.484 · Cited by 184 · see citing works

Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin

Basu, S., Golovina, T. N., Mikheeva, T., June, C. H., & Riley, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5794 · Cited by 183 · see citing works

Soluble Fas Ligand Is Chemotactic for Human Neutrophilic Polymorphonuclear Leukocytes

Ottonello, L. C., Tortolina, G., Amelotti, M., & Dallegri, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3601 · Cited by 177 · see citing works

Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes

Phelps, E. A., Headen, D. M., Taylor, W. R., Thulé, P. M., & Garcı́a, A. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.012 · Cited by 170 · see citing works

Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites

Weaver, J. D., Headen, D. M., Aquart, J., Johnson, C. T., Shea, L. D., Shirwan, H., & García, A. J. (2017) · Science Advances · doi:10.1126/sciadv.1700184 · Cited by 170 · see citing works

Bioengineering of an Intraabdominal Endocrine Pancreas

Baidal, D. A., Ricordi, C., Berman, D. M., Alvarez, A., Padilla, N., Ciancio, G., Linetsky, E., Pileggi, A., & Alejandro, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1613959 · Cited by 160 · see citing works

Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells

Matsue, H., Matsue, K., Walters, M., Okumura, K., Yagita∥, H., & Takashima, A. (1999) · Nature Medicine · doi:10.1038/11375 · Cited by 157 · see citing works

Long-Term Function (6 Years) of Islet Allografts in Type 1 Diabetes

Alejandro, R., Lehmann, R., Ricordi, C., Kenyon, N. S., Angelico, M. C., Burke, G. W., Esquenazi, V., Nery, J., Betancourt, A., Kong, S. S., et al. (1997) · Diabetes · doi:10.2337/diab.46.12.1983 · Cited by 152 · see citing works

Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold

Berman, D., Molano, R., Fotino, C., Ulissi, U., Gimeno, J., Mendez, A. J., Kenyon, N., Kenyon, N. S., Andrews, D. M., Ricordi, C., et al. (2016) · Diabetes · doi:10.2337/db15-1525 · Cited by 129 · see citing works

FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable Outcomes

Bunnag, S., Allanach, K., Jhangri, G. S., Sis, B., Einecke, G., Mengel, M., Mueller, T., & Halloran, P. F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02268.x · Cited by 128 · see citing works

Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice

Hurez, V. J., Dao, V. A., Liu, A., Pandeswara, S., Gelfond, J., Sun, L., Bergman, M. A., Orihuela, C. J., Galván, V., Padron, A. S., et al. (2015) · Aging Cell · doi:10.1111/acel.12380 · Cited by 127 · see citing works

High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1

Yellen, P., Saqcena, M., Salloum, D., Feng, J., Preda, A., Xu, L., Rodrik-Outmezguine, V. S., & Foster, D. A. (2011) · Cell Cycle · doi:10.4161/cc.10.22.18124 · Cited by 117 · see citing works

Priming and effector dependence on insulin B:9–23 peptide in NOD islet autoimmunity

Nakayama, M., Beilke, J. N., Jasinski, J., Kobayashi, M., Miao, D., Li, M., Coulombe, M., Liu, E., Elliott, J. F., Gill, R. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31368 · Cited by 109 · see citing works

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

Yolcu, E., Askenasy, N., Singh, N., Cherradi, S., & Shirwan, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00482-x · Cited by 106 · see citing works

Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity

Radu, R. G., Fujimoto, S., Mukai, E., Takehiro, M., Shimono, D., Nabe, K., Shimodahira, M., Kominato, R., Aramaki, Y., Nishi, Y., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2004 · Cited by 85 · see citing works

Pancreatic Islets Engineered with SA-FasL Protein Establish Robust Localized Tolerance by Inducing Regulatory T Cells in Mice

Yolcu, E. S., Zhao, H., Bandura-Morgan, L., Lacelle, C., Woodward, K. B., Askenasy, N., & Shirwan, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003266 · Cited by 82 · see citing works

Inhibition of the alloantibody response by CD95 ligand

Arai, H., Chanz, S. Y., Bishop, D. K., & Nabel, G. J. (1997) · Nature Medicine · doi:10.1038/nm0897-843 · Cited by 81 · see citing works

Apoptosis as a mechanism of T‐regulatory cell homeostasis and suppression

Yolcu, E. S., Ash, S., Kaminitz, A., Sagiv, Y., Askenasy, N., & Yarkoni, S. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.62 · Cited by 65 · see citing works

Tacrolimus‐Induced Diabetes in Rats Courses with Suppressed Insulin Gene Expression in Pancreatic Islets

Hernández-Fisac, I., Pizarro‐Delgado, J., Calle, C., Marqués, M., Sánchez, A., Barrientos, A., & Tamarit‐Rodriguez, J. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01946.x · Cited by 58 · see citing works

Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts

Takeda, Y., Gotoh, M., Dono, K., Nishihara, M., Grochowiecki, T., Kimura, F., Yoshida, T., Ohta, Y., Ota, H., Ohzato, H., et al. (1998) · Diabetologia · doi:10.1007/s001250050909 · Cited by 57 · see citing works

Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients

Boggi, U., Vistoli, F., Amorese, G., GIANNARELLI, R., Coppelli, A., Mariotti, R., Rondinini, L., Barsotti, M., Signori, S., Lio, N. D., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318247a782 · Cited by 50 · see citing works

Transgenic Expression of CD95 Ligand on Thyroid Follicular Cells Confers Immune Privilege upon Thyroid Allografts

Tourneur, L., Malassagne, B., Batteux, F., Fabrè, M., Mistou, S., Lallemand, E., Lorès, P., & Chiocchia, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1338 · Cited by 34 · see citing works

Intragraft FOXP3 Protein or mRNA During Acute Renal Allograft Rejection Correlates With Inflammation, Fibrosis, and Poor Renal Outcome

Yapici, Ü., Bemelman, F. J., Scheepstra, C. G., Roelofs, J. J. T. H., Claessen, N., van der Loos, C. M., der Pant, K. A. M. I. V. D., Bouts, A. H. M., Idu, M. M., Rowshani, A. T., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a24a4b · Cited by 28 · see citing works

Hydrogel microparticles for biomedical applications

Daly, A. C., Riley, L., Segura, T., & Burdick, J. A. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0148-6 · Cited by 1,269 · see citing works

Structurally Dynamic Hydrogels for Biomedical Applications: Pursuing a Fine Balance between Macroscopic Stability and Microscopic Dynamics

Zhang, K., Feng, Q., Fang, Z., Gu, L., & Bian, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00071 · Cited by 397 · see citing works

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210 · see citing works

Anisotropic Rod‐Shaped Particles Influence Injectable Granular Hydrogel Properties and Cell Invasion

Qazi, T. H., Wu, J., Muir, V. G., Weintraub, S., Gullbrand, S. E., Lee, D., Issadore, D., & Burdick, J. A. (2021) · Advanced Materials · doi:10.1002/adma.202109194 · Cited by 181 · see citing works

Hydrogels in Emerging Technologies for Type 1 Diabetes

Fuchs, S., Ernst, A. U., Wang, L., Shariati, K., Wang, X., Liu, Q., & Ma, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01062 · Cited by 160 · see citing works

Biomaterials for Personalized Cell Therapy

Facklam, A. L., Volpatti, L. R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201902005 · Cited by 150 · see citing works

Injectable biomaterials for translational medicine

Zhou, H., Liang, C., Wei, Z., Bai, Y., Bhaduri, S. B., Webster, T. J., Bian, L., & Yang, L. (2019) · Materials Today · doi:10.1016/j.mattod.2019.04.020 · Cited by 140 · see citing works

Engineering immunomodulatory biomaterials for type 1 diabetes

Stabler, C. L., Li, Y., Stewart, J. M., & Keselowsky, B. G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0112-5 · Cited by 126 · see citing works

Strategies for durable β cell replacement in type 1 diabetes

Brusko, T. M., Russ, H. A., & Stabler, C. L. (2021) · Science · doi:10.1126/science.abh1657 · Cited by 119 · see citing works

Immunomodulatory injectable silk hydrogels maintaining functional islets and promoting anti-inflammatory M2 macrophage polarization.

Kumar, M., Gupta, P., Bhattacharjee, S., Nandi, S. K., & Mandal, B. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.037 · Cited by 92 · see citing works

Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers

Yerneni, S. S., Lathwal, S., Shrestha, P., Shirwan, H., Matyjaszewski, K. A., Weiss, L. E., Yolcu, E. S., Campbell, P. G., & Das, S. R. (2019) · ACS Nano · doi:10.1021/acsnano.9b04651 · Cited by 111 · see citing works

Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival

Coronel, M. M., Martin, K. E., Hunckler, M. D., Barber, G., O’Neill, E. B., Medina, J. D., Opri, E., McClain, C. A., Batra, L., Weaver, J. D., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba5573 · Cited by 89 · see citing works

Polymeric Approaches to Reduce Tissue Responses Against Devices Applied for Islet-Cell Encapsulation

Hu, S., & de Vos, P. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00134 · Cited by 85 · see citing works

Modulating the foreign body response of implants for diabetes treatment

Kharbikar, B. N., Chendke, G. S., & Desai, T. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.011 · Cited by 83 · see citing works

FasL microgels induce immune acceptance of islet allografts in nonhuman primates

Lei, J., Coronel, M. M., Yolcu, E. S., Deng, H., Grimany-Nuno, O., Hunckler, M. D., Ulker, V., Yang, Z., Lee, K. M., Zhang, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm9881 · Cited by 77 · see citing works

Recent Advances in Microgels: From Biomolecules to Functionality

Xu, Y., Zhu, H., Denduluri, A. J., Ou, Y., Erkamp, N. A., Qi, R., Shen, Y., & Knowles, T. P. J. (2022) · Small · doi:10.1002/smll.202200180 · Cited by 79 · see citing works

Human beige adipocytes for drug discovery and cell therapy in metabolic diseases

Singh, A. M., Zhang, L., Avery, J. W., Yin, A., Du, Y., Wang, H., Li, Z., Fu, H., Yin, H., & Dalton, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16340-3 · Cited by 78 · see citing works

Engineering Immune Tolerance with Biomaterials

Gammon, J. M., & Jewell, C. M. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801419 · Cited by 77 · see citing works

Nanotechnology in cell replacement therapies for type 1 diabetes

Ernst, A. U., Bowers, D. T., Wang, L., Shariati, K., Plesser, M. D., Brown, N. K., Mehrabyan, T., & Ma, M. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.013 · Cited by 74 · see citing works

Engineered microscale hydrogels for drug delivery, cell therapy, and sequencing

Wechsler, M. E., Stephenson, R. E., Murphy, A. C., Oldenkamp, H. F., Singh, A. K., & Peppas, N. A. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0358-0 · Cited by 74 · see citing works

4D Printing of Extrudable and Degradable Poly(Ethylene Glycol) Microgel Scaffolds for Multidimensional Cell Culture

Miksch, C. E., Skillin, N. P., Kirkpatrick, B. E., Hach, G. K., Rao, V. V., White, T. J., & Anseth, K. S. (2022) · Small · doi:10.1002/smll.202200951 · Cited by 68 · see citing works

Tricolor visible wavelength-selective photodegradable hydrogel biomaterials

Rapp, T. L., & DeForest, C. A. (2023) · Nature Communications · doi:10.1038/s41467-023-40805-w · Cited by 68 · see citing works

Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells

Purwada, A., Shah, S. B., Béguelin, W., August, A., Melnick, A. M., & Singh, A. K. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.034 · Cited by 60 · see citing works

The Antitumor Activities of Marsdenia tenacissima

Wang, X., Yan, Y., Chen, X., Zeng, S., Qian, L., Ren, X., Wei, J., Yang, X., Zhou, Y., Gong, Z., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00473 · Cited by 58 · see citing works

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

Wang, X., Brown, N. K., Wang, B., Shariati, K., Wang, K., Fuchs, S., Melero‐Martin, J. M., & Ma, M. (2021) · Advanced Science · doi:10.1002/advs.202003708 · Cited by 57 · see citing works

Clinical islet transplantation: Current progress and new frontiers

Marfil-Garza, B., Shapiro, A. M., & Kin, T. (2021) · Journal of hepato-biliary-pancreatic sciences · doi:10.1002/jhbp.891 · Cited by 43 · see citing works

Direct Comparison of Angiogenesis in Natural and Synthetic Biomaterials Reveals Matrix Porosity Regulates Endothelial Cell Invasion Speed and Sprout Diameter

Wang, W. Y., Kent, R., Huang, S. A., Jarman, E. H., Shikanov, E. H., Davidson, C. D., Hiraki, H. L., Lin, D., Wall, M. A., Matera, D. L., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.08.038 · Cited by 58 · see citing works

Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases

Risso, V., Lafont, É., & Gallo, M. L. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04688-x · Cited by 58 · see citing works

Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression

Wang, X., Wang, K., Yu, M., Velluto, D., Hong, X., Wang, B., Chiu, A., Melero-Martin, J. M., Tomei, A. A., & Ma, M. (2022) · Science Advances · doi:10.1126/sciadv.abn0071 · Cited by 62 · see citing works

Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas

Shah, S. B., Carlson, C. R., Lai, K., Zhong, Z., Marsico, G., Lee, K. M., Vélez, N. E. F., Abeles, E. B., Allam, M., Hu, T., et al. (2023) · Nature Materials · doi:10.1038/s41563-023-01495-3 · Cited by 52 · see citing works

Biomaterials-assisted spheroid engineering for regenerative therapy

Lee, N., Bayaraa, O., Zechu, Z., & Kim, H. S. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.7.059 · Cited by 51 · see citing works

Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond

Abbaszadeh, S., Nosrati‐Siahmazgi, V., Musaie, K., Rezaei, S., Qahremani, M., Xiao, B., Santos, H. A., & Shahbazi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115050 · Cited by 51 · see citing works

Local delivery strategies to restore immune homeostasis in the context of inflammation

Bentley, E. R., & Little, S. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113971 · Cited by 49 · see citing works

Advances in Cell Replacement Therapies for Diabetes

Hering, B. J., Rickels, M. R., Bellin, M. D., Millman, J. R., Tomei, A. A., Garcı́a, A. J., Shirwan, H., Stabler, C. L., Ma, M., Peng, Y., et al. (2025) · Diabetes · doi:10.2337/db25-0037 · Cited by 49 · see citing works

Localized immune tolerance from FasL-functionalized PLG scaffolds

Skoumal, M., Woodward, K. B., Zhao, H., Wang, F., Yolcu, E., Pearson, R. M., Hughes, K., García, A. J., Shea, L., & Shirwan, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.015 · Cited by 44 · see citing works

Islet encapsulation

Ernst, A. U., Wang, L., & Ma, M. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02020e · Cited by 47 · see citing works

Biomaterials-Mediated Engineering of the Immune System

Backlund, C. M., Jalili‐Firoozinezhad, S., Kim, B., & Irvine, D. J. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-040259 · Cited by 48 · see citing works

Emerging immunomodulatory strategies for cell therapeutics

Chua, C. Y. X., Jiang, A. Y., Eufrásio-da-Silva, T., Dolatshahi‐Pirouz, A., Langer, R., Orive, G., & Grattoni, A. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.11.008 · Cited by 46 · see citing works

Exosome loaded immunomodulatory biomaterials alleviate local immune response in immunocompetent diabetic mice post islet xenotransplantation

Mohammadi, M. R., Rodriguez, S. M., Luong, J. C., Li, S., Cao, R., Alshetaiwi, H., Lau, H., Davtyan, H., Jones, M. B., Jafari, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02229-4 · Cited by 53 · see citing works

Injectable hydrogels for islet transplantation: a concise review

Shrestha, P. S., Regmi, S., & Jeong, J. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00433-3 · Cited by 42 · see citing works

Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression

Batra, L., Shrestha, P., Zhao, H., Woodward, K. B., Togay, A., Tan, M., Grimany-Nuno, O., Malik, M. T., Coronel, M. M., Garcı́a, A. J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000055 · Cited by 42 · see citing works

Immunoisolation of pancreatic islets via thin-layer surface modification

Pathak, S., Pham, T. T., Jeong, J., & Byun, Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.034 · Cited by 40 · see citing works

Type 1 diabetes and engineering enhanced islet transplantation

Jeyagaran, A., Lu, C., Zbinden, A., Birkenfeld, A. L., Brucker, S. Y., & Layland, S. L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114481 · Cited by 41 · see citing works

Rapid and Long‐Term Glycemic Regulation with a Balanced Charged Immune‐Evasive Hydrogel in T1DM Mice

Zhang, J., Zhu, Y., Song, J., Xu, T., Yang, J., Du, Y., & Zhang, L. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900140 · Cited by 39 · see citing works

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer

Wu, Q., Li, Q., Zhu, W., Zhang, X., & Li, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16378 · Cited by 38 · see citing works

Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes

Samojlik, M. M., & Stabler, C. L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.039 · Cited by 38 · see citing works

Biohybrid Nanoparticles to Negotiate with Biological Barriers

Mohammadi, M. R., Corbo, C., Molinaro, R., & Lakey, J. R. T. (2019) · Small · doi:10.1002/smll.201902333 · Cited by 37 · see citing works

Hydrolytically Degradable Microgels with Tunable Mechanical Properties Modulate the Host Immune Response

Coronel, M. M., Martin, K. E., Hunckler, M. D., Kalelkar, P. P., Shah, R. M., & Garcı́a, A. J. (2022) · Small · doi:10.1002/smll.202106896 · Cited by 38 · see citing works

Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering

Krentz, N. A. J., Shea, L. D., Huising, M. O., & Shaw, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00170-4 · Cited by 37 · see citing works

Encapsulated islet transplantation

Liu, S. S., Shim, S., Kudo, Y., Stabler, C. L., O’Cearbhaill, E. D., Karp, J. M., & Yang, K. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00238-6 · Cited by 41 · see citing works

Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege

Woodward, K. B., Zhao, H., Shrestha, P., Batra, L., Tan, M., Grimany-Nuno, O., Bandura-Morgan, L., Askenasy, N., Shirwan, H., & Yolcu, E. S. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15747 · Cited by 35 · see citing works

Enhancing longevity of immunoisolated pancreatic islet grafts by modifying both the intracapsular and extracapsular environment

Qin, T., Smink, A. M., & de Vos, P. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.038 · Cited by 35 · see citing works

Microfluidic Generation of Multicomponent Soft Biomaterials

Wang, Y., Shang, L., Zhao, Y., & Sun, L. (2022) · Engineering · doi:10.1016/j.eng.2021.02.026 · Cited by 34 · see citing works

Mesenchymal Stem Cell‐Laden Composite β Cell Porous Microgel for Diabetes Treatment

Sun, J., Li, J., Huan, Z., Pandol, S. J., Liu, D., Shang, L., & Li, L. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202211897 · Cited by 33 · see citing works

Sprayed Aqueous Microdroplets for Spontaneous Synthesis of Functional Microgels

Li, X., Zhang, W., Li, H., Shuai, Q., Zhang, X., & Pich, A. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202420926 · Cited by 33 · see citing works

Granular Hydrogels for Harnessing the Immune Response

Widener, A. E., Roberts, A., & Phelps, E. A. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303005 · Cited by 32 · see citing works

Functionalization of in vivo tissue-engineered living biotubes enhance patency and endothelization without the requirement of systemic anticoagulant administration

Yan, H., Cheng, Q., Si, J., Wang, S., Wan, Y., Kong, X., Wang, T., Zheng, W., Rafique, M., Li, X., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.03.003 · Cited by 30 · see citing works

Encapsulation and immune protection for type 1 diabetes cell therapy

Kioulaphides, S., & Garcı́a, A. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115205 · Cited by 34 · see citing works

Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants

Li, Y., Frei, A. W., Labrada, I., Rong, Y., Liang, J.-P., Samojlik, M. M., Sun, C., Barash, S. D., Keselowsky, B., Bayer, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653088 · Cited by 35 · see citing works

Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation

Wang, Y., Huang, R., Lu, Y., Liu, M., & Mo, R. (2024) · Nature Communications · doi:10.1038/s41467-024-49135-x · Cited by 28 · see citing works

Spatiotemporal material functionalization via competitive supramolecular complexation of avidin and biotin analogs

Kamperman, T., Koerselman, M., Kelder, C., Hendriks, J., Crispim, J. F., de Peuter, X., Dijkstra, P. J., Karperien, M., & Leijten, J. (2019) · Nature Communications · doi:10.1038/s41467-019-12390-4 · Cited by 28 · see citing works

Transplantation of Islet-Containing microcapsules modified with constitutional isomers of sulfated alginate in diabetic mice to mitigate fibrosis for Long-term glycemic control

Samsonchi, Z., Karimi, H., Izadi, Z., Baei, P., Najarasl, M., Ashtiani, M. K., Mohammadi, J., Moazenchi, M., Tahamtani, Y., Baharvand, H., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134298 · Cited by 27 · see citing works

Sustained‐immunostimulatory nanocellulose scaffold to enhance vaccine efficacy

Nishiguchi, A., & Taguchi, T. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36890 · Cited by 28 · see citing works

Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation

Campa‐Carranza, J. N., Paez‐Mayorga, J., Chua, C. Y. X., Nichols, J. E., & Grattoni, A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2076834 · Cited by 28 · see citing works

Pluripotent Stem Cell-Derived Pancreatic Progenitors and β-Like Cells for Type 1 Diabetes Treatment.

Sambathkumar, R., Migliorini, A., & Nostro, M. (2018) · Physiology · doi:10.1152/physiol.00026.2018 · Cited by 22 · see citing works

The impact of locally-delivered tacrolimus-releasing microspheres and polyethylene glycol-based islet surface modification on xenogeneic islet survival.

Nguyen, T., Phung, C. D., Kim, J. O., Yong, C., Kim, J.-R., Yook, S., & Jeong, J.-H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.020 · Cited by 22 · see citing works

Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I

Santini-González, J., Castro-Gutiérrez, R., Becker, M. W., Rancourt, C., Russ, H. A., & Phelps, E. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989815 · Cited by 26 · see citing works

Immune checkpoint CD47 molecule engineered islets mitigate instant blood‐mediated inflammatory reaction and show improved engraftment following intraportal transplantation

Shrestha, P., Batra, L., Malik, M. T., Tan, M., Yolcu, E., & Shirwan, H. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15958 · Cited by 20 · see citing works

Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening

O’Melia, M. J., Mulero‐Russe, A., Kim, J., Pybus, A. F., DeRyckere, D., Wood, L. B., Graham, D. K., Botchwey, E. A., Garcı́a, A. J., & Thomas, S. N. (2022) · Advanced Materials · doi:10.1002/adma.202108084 · Cited by 23 · see citing works

Cell and biomaterial delivery strategies to induce immune tolerance

Scotland, B. L., Shaw, J. R., Dharmaraj, S., Caprio, N., Cottingham, A. L., Lasola, J. J., Sung, J. J., & Pearson, R. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115141 · Cited by 25 · see citing works

Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity

Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 22 · see citing works

Immunoprotection Strategies in β‐Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation

Grimus, S., Sarangova, V., Welzel, P. B., Ludwig, B., Seißler, J., Kemter, E., Wolf, E., & Ali, A. (2024) · Advanced Science · doi:10.1002/advs.202401385 · Cited by 21 · see citing works

Targeting Type 1 Diabetes: Selective Approaches for New Therapies

Sheehy, D. F., Quinnell, S. P., & Vegas, A. J. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01118 · Cited by 22 · see citing works

Biomaterials with droplet microfluidics

Ou, Y., Han, Z., Cai, D. S., Heck, J. R., Toprakcioglu, Z., Yu, Z., Weitz, D. A., & Knowles, T. P. J. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00389-0 · Cited by 23 · see citing works

Immunoengineering has arrived

Green, J. J. (2021) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37041 · Cited by 24 · see citing works

Immune Checkpoint‐Bioengineered Beta Cell Vaccine Reverses Early‐Onset Type 1 Diabetes

Au, K. M., Medik, Y. B., Qi, K., Tisch, R., & Wang, A. Z. (2021) · Advanced Materials · doi:10.1002/adma.202101253 · Cited by 21 · see citing works

Co-transplantation of Islets-Laden Microgels and Biodegradable O2-Generating Microspheres for Diabetes Treatment.

Huang, H.-H., Shang, Y., Li, H., Feng, Q., Liu, Y., Chen, J., & Dong, H. (2022) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.2c07215 · Cited by 21 · see citing works

iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine

Hui, K. K., & Yamanaka, S. (2024) · BioEssays · doi:10.1002/bies.202400072 · Cited by 22 · see citing works

Current State and Evidence of Cellular Encapsulation Strategies in Type 1 Diabetes

Marfil‐Garza, B. A., Polishevska, K., Pepper, A. R., & Korbutt, G. S. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190033 · Cited by 22 · see citing works

Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

Paul, P. K., Das, R., Drow, T., Nylen, E. A., de Souza, A. H., Wang, Z., Wood, M. W., Davis, D. B., Bjorling, D. E., & Galipeau, J. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17162 · Cited by 19 · see citing works

Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates

Deng, H., Zhang, A., Pang, D., Xi, Y., Yang, Z.-H., Matheson, R., Li, G., Luo, H., Lee, K. M., Fu, Q., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100959 · Cited by 21 · see citing works

Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes

Derakhshankhah, H., Sajadimajd, S., Jahanshahi, F., Samsonchi, Z., Karimi, H., Hajizadeh-Saffar, E., Jafari, S., Razmi, M., Malvajerd, S. S., Bahrami, G., et al. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0134 · Cited by 20 · see citing works

Particulate‐Based Single‐Dose Local Immunosuppressive Regimen for Inducing Tolerogenic Dendritic Cells in Xenogeneic Islet Transplantation

Pathak, S., Acharya, S., Regmi, S., Shrestha, P., You, Z., Bae, Y., Park, M., Yook, S., Kim, J.-R., Park, S., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001157 · Cited by 19 · see citing works

Bio‐Orthogonal, Site‐Selective Conjugation of Recombinant Proteins to Microporous Annealed Particle Hydrogels for Tissue Engineering

Jivan, F., & Alge, D. L. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900148 · Cited by 18 · see citing works

Engineering β Cell Replacement Therapies for Type 1 Diabetes: Biomaterial Advances and Considerations for Macroscale Constructs

Quizon, M. J., & Garcı́a, A. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-094846 · Cited by 18 · see citing works

A hydrogel platform for co‐delivery of immunomodulatory proteins for pancreatic islet allografts

Medina, J. D., Barber, G. F., Coronel, M. M., Hunckler, M. D., Linderman, S. W., Quizon, M. J., Ulker, V., Yolcu, E. S., Shirwan, H., & Garcı́a, A. J. (2022) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37429 · Cited by 18 · see citing works

Localized immunomodulation technologies to enable cellular and organoid transplantation

Nash, A., Lokhorst, N., & Omid Veiseh, A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.05.008 · Cited by 18 · see citing works

Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge

Caldara, R., Tomajer, V., Monti, P., Sordi, V., Citro, A., Chimienti, R., Gremizzi, C., Catarinella, D., Tentori, S., Paloschi, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323439 · Cited by 19 · see citing works

Osteoimmunology: An Overview of the Interplay of the Immune System and the Bone Tissue in Fracture Healing

Letaifa, R. B., Klaylat, T., Tarchala, M., Gao, C., Schneider, P., Rosenzweig, D. H., Martineau, P. A., & Gawri, R. (2024) · Surgeries · doi:10.3390/surgeries5020033 · Cited by 18 · see citing works

Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease

Kim, K. M., D’Elia, A. M., & Rodell, C. B. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115395 · Cited by 19 · see citing works

Controlled Release of Stem Cell Secretome Attenuates Inflammatory Response against Implanted Biomaterials

Mohammadi, M. R., Luong, J. C., Rodriguez, S., Cao, R., Wheeler, A., Lau, H., Li, S., Shabestari, S. K., Chadarevian, J. P., Alexander, M., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901874 · Cited by 18 · see citing works

Advances in injectable hydrogels with biological and physicochemical functions for cell delivery

Nishiguchi, A. (2024) · Polymer Journal · doi:10.1038/s41428-024-00934-5 · Cited by 19 · see citing works

Gelatin maleimide microgels for hematopoietic progenitor cell encapsulation

Thompson, G. B., Gilchrist, A. E., Lam, V. M., Nunes, A. C., Payan, B. A., Mora‐Boza, A., Serrano, J. F., Garcı́a, A. J., & Harley, B. A. C. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37765 · Cited by 17 · see citing works

Engineered microenvironments and microdevices for modeling the pathophysiology of type 1 diabetes

Becker, M. W., Simonovich, J. A., & Phelps, E. A. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.002 · Cited by 17 · see citing works

Emerging molecular technologies for light-mediated modulation of pancreatic beta-cell function

Chen, Z., Truskinovsky, L. F., & Tzanakakis, E. S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101552 · Cited by 15 · see citing works

Extrahepatic transplantation of 3D cultured stem cell-derived islet organoids on microporous scaffolds

Bealer, E. J., Crumley, K. M., Clough, D., King, J. L., Behrend, M., Annulis, C., Li, F., Soleimanpour, S. A., & Shea, L. D. (2023) · Biomaterials Science · doi:10.1039/d3bm00217a · Cited by 16 · see citing works

Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy

Coronel, M. M., Linderman, S. W., Martin, K. E., Hunckler, M. D., Medina, J. D., Barber, G. F., Riley, K., Yolcu, E. S., Shirwan, H., & Garcı́a, A. J. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.07.023 · Cited by 16 · see citing works

Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment

Mashayekhi, K., Khazaie, K., Faubion, W., & Kim, G. B. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.03.030 · Cited by 21 · see citing works

Modulating immune responses for enhanced cell therapies: The dual role of multi-scale biomaterials

Zeng, J., Jin, Y., Ao, Y.-X., Li, W.-J., Liang, K.-N., Chen, H., Long, Y., & Du, Y.-N. (2024) · EngMedicine · doi:10.1016/j.engmed.2024.100038 · Cited by 16 · see citing works

Integration of Islet/Beta-Cell Transplants with Host Tissue Using Biomaterial Platforms

Clough, D., King, J. L., Li, F., & Shea, L. D. (2020) · Endocrinology · doi:10.1210/endocr/bqaa156 · Cited by 16 · see citing works

SA-FasL-engineered PEG microgels as a novel means of modulating immune response to allogeneic islet grafts

Shirwan, H., Woodward, K. B., Headen, D. M., Zhao, H., Shrestha, P., Tan, M., Bowen, W. S., Coronel, M. M., Hunckler, M. D., Weaver, J. D., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.200.supp.55.36 · Cited by 3 · see citing works

Immunomodulation with SA-FasL-Engineered Microgels Achieves Long-Term Survival of Allogeneic Islet Grafts

Woodward, K. B., Headen, D. M., Shrestha, P., Tan, M., Bowen, W. S., Coronel, M. M., Hunckler, M. D., Weaver, J. D., Yolcu, E. S., Garcı́a, A. J., et al. (2018) · Transplantation · doi:10.1097/01.tp.0000542995.31760.b5

334.3: Presentation of FasL Protein by PEG Microgels Within Graft Site Leads to Survival of Pancreatic Islets in Nonhuman Primates Without the Need for Chronic Immunosuppression

Yolcu, E. S., Lei, J., Coronel, M. M., Deng, H., Yang, Z., Zhang, A., Chen, T., Lee, K. M., Peters, C. W., Rosales, I. A., et al. (2022) · Transplantation · doi:10.1097/01.tp.0000886892.56456.65

FasL microgels induce immune acceptance of islet allografts in nonhuman primates

Lei, J., Coronel, M. M., Yolcu, E. S., Deng, H., Grimany-Nuno, O., Hunckler, M. D., Ulker, V., Yang, Z., Lee, K. M., Zhang, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm9881 · Cited by 77 · see citing works

Localized immune tolerance from FasL-functionalized PLG scaffolds

Skoumal, M., Woodward, K. B., Zhao, H., Wang, F., Yolcu, E., Pearson, R. M., Hughes, K., García, A. J., Shea, L., & Shirwan, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.015 · Cited by 44 · see citing works